Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia.
D000818:Animals; D004353:Drug Evaluation, Preclinical; D005260:Female; D007274:Injections, Intraperitoneal; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D051379:Mice; D009368:Neoplasm Transplantation; D011034:Podophyllotoxin / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D013997:Time Factors; D014184:Transplantation, Homologous
D011034:Podophyllotoxin